ClinicalTrials.Veeva

Menu

No Reflow Phenomenon Incidence and Predictors (NORM-PPCI)

NHS Trust logo

NHS Trust

Status

Completed

Conditions

No Reflow Phenomenon
STEMI

Treatments

Other: No intervention as observational study

Study type

Observational

Funder types

Other

Identifiers

NCT04017169
NORM PPCI

Details and patient eligibility

About

Background No reflow phenomenon is described in up to 65% of patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction (STEMI). It is known to be associated with worse outcomes but predictors of no reflow are not clearly described.

Objectives A single centre case-control observational study of patients presenting with acute myocardial infarction appropriate for PPCI comparing baseline clinical, biochemical and angiographic characteristics between patients with no reflow phenomenon and those without. Aiming to establish incidence for the UK population.

Secondary outcomes will be to gain further insight into those presenting with STEMI for PPCI and develop a risk model to guide management and clinical outcomes of patients to 30days.

Methods This study will prospectively recruit all consecutive patients attending a single centre for primary percutaneous coronary intervention for STEMI. Angiographic assessment of the recanalised epicardial vessel will be used to diagnose no reflow (reduced TIMI flow or blush grade). Baseline demographic, angiographic and biochemical characteristics and outcomes at 30days for reflow and no reflow cohorts will be statistically assessed and compared with logistic regression.

Enrollment

176 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 18 years
  • Presenting with ST elevation myocardial infarction
  • Appropriate for Primary Percutaneous Coronary Intervention

Exclusion criteria

  • Primary Percutaneous Coronary Intervention not performed eg due to non- flow- limiting coronary artery disease
  • Unsuccessful PCI
  • Thrombolysis
  • Patients who do not survive the procedure to leave the catheterisation laboratory

Trial design

176 participants in 2 patient groups

No reflow phenomenon
Description:
Those that during procedure experience no reflow phenomenon To define no reflow requires: • Angiographic evidence of reopening of occluded coronary artery and successful stent placement with no evidence of flow-limiting residual stenosis (\<50%), dissection, vessel spasm, or thrombus burden and * Angiographic documentation of a TIMI flow grade ≤II, or * A TIMI flow grade III with a myocardial perfusion grade 0 or I, at least 10 min after the end of PCI procedure.
Treatment:
Other: No intervention as observational study
No NRP
Description:
Normal angiographic coronary flow/blush post patent culprit vessel.
Treatment:
Other: No intervention as observational study

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems